Bayesian Hierarchical Piecewise‐Exponential Cause‐Specific Hazards for Posterior Predictive Validation of Competing‐Risks Models
Statistics in Medicine · 2026-11 · 45 (25-27)
DOI: 10.1002/sim.70812 ↗Astratt
ABSTRACT Competing‐risks prediction requires validation methods that assess predictive support for both event time and event type. This is difficult for cause‐specific hazard models because out‐of‐sample log‐scores require positive, well‐defined hazards over the validation horizon, and rare event causes can lead to unstable cause‐specific estimates. We develop the Bayesian hierarchical piecewise‐exponential cause‐specific hazards model (), a competing‐risks model designed for posterior predictive validation using cross‐validated log‐scores. The model specifies positive piecewise‐exponential baseline hazards for each cause and places hierarchical priors on cause‐specific regression coefficients, allowing covariate effects to borrow information across causes while retaining cause‐specific interpretation. Predictive performance is evaluated using cross‐validated posterior predictive log‐scores under the cause‐specific hazards representation. Simulation studies show that the Bayesian piecewise‐exponential framework improves out‐of‐sample predictive support and model‐selection performance across settings with varying signal strength, sample size, censoring, cause imbalance, and cross‐cause heterogeneity. Hierarchical pooling provides the largest benefit when cross‐cause heterogeneity is low to moderate, event causes are imbalanced, or information for rare causes is limited. When true cause‐specific effects are highly heterogeneous, the advantage of partial pooling diminishes, reflecting the expected bias–variance trade‐off. A Surveillance, Epidemiology, and End Results (SEER) colorectal cancer application further demonstrates the practical utility of the method: the treatment‐extended specification evaluated with achieves the best predictive performance, and hierarchical pooling narrows posterior credible intervals for selected rare‐cause coefficients. These findings support as a stable Bayesian posterior predictive framework for imbalanced multi‐cause competing‐risks prediction.
EUVIMED